1. Home
  2. MBBC vs OVID Comparison

MBBC vs OVID Comparison

Compare MBBC & OVID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MBBC
  • OVID
  • Stock Information
  • Founded
  • MBBC 1902
  • OVID 2014
  • Country
  • MBBC United States
  • OVID United States
  • Employees
  • MBBC N/A
  • OVID N/A
  • Industry
  • MBBC Banks
  • OVID Biotechnology: Pharmaceutical Preparations
  • Sector
  • MBBC Finance
  • OVID Health Care
  • Exchange
  • MBBC Nasdaq
  • OVID Nasdaq
  • Market Cap
  • MBBC 22.1M
  • OVID 20.6M
  • IPO Year
  • MBBC N/A
  • OVID 2017
  • Fundamental
  • Price
  • MBBC $10.01
  • OVID $0.27
  • Analyst Decision
  • MBBC
  • OVID Strong Buy
  • Analyst Count
  • MBBC 0
  • OVID 6
  • Target Price
  • MBBC N/A
  • OVID $2.78
  • AVG Volume (30 Days)
  • MBBC 10.5K
  • OVID 441.7K
  • Earning Date
  • MBBC 05-14-2025
  • OVID 05-13-2025
  • Dividend Yield
  • MBBC N/A
  • OVID N/A
  • EPS Growth
  • MBBC 103.56
  • OVID N/A
  • EPS
  • MBBC 0.22
  • OVID N/A
  • Revenue
  • MBBC $6,591,743.00
  • OVID $548,000.00
  • Revenue This Year
  • MBBC N/A
  • OVID N/A
  • Revenue Next Year
  • MBBC N/A
  • OVID $21.49
  • P/E Ratio
  • MBBC $45.44
  • OVID N/A
  • Revenue Growth
  • MBBC N/A
  • OVID 15.61
  • 52 Week Low
  • MBBC $5.83
  • OVID $0.24
  • 52 Week High
  • MBBC $12.00
  • OVID $3.31
  • Technical
  • Relative Strength Index (RSI)
  • MBBC N/A
  • OVID 38.31
  • Support Level
  • MBBC N/A
  • OVID $0.28
  • Resistance Level
  • MBBC N/A
  • OVID $0.31
  • Average True Range (ATR)
  • MBBC 0.00
  • OVID 0.02
  • MACD
  • MBBC 0.00
  • OVID 0.00
  • Stochastic Oscillator
  • MBBC 0.00
  • OVID 0.34

About OVID Ovid Therapeutics Inc.

Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.

Share on Social Networks: